114 related articles for article (PubMed ID: 11266952)
1. Prolonged class II MHC disparate skin allograft survival by treatment with antibodies to the chemokine Mig.
Koga S; Kobayashi H; Novick AC; Toma H; Fairchild RL
Transplant Proc; 2001; 33(1-2):549-50. PubMed ID: 11266952
[No Abstract] [Full Text] [Related]
2. Chronic antagonism of Mig inhibits cellular infiltration and promotes survival of class II MHC disparate skin allografts.
Kobayashi H; Novick AC; Toma H; Fairchild RL
Transplantation; 2002 Aug; 74(3):387-95. PubMed ID: 12177619
[TBL] [Abstract][Full Text] [Related]
3. Intraallograft chemokine RNA and protein during rejection of MHC-matched/multiple minor histocompatibility-disparate skin grafts.
Watarai Y; Koga S; Paolone DR; Engeman TM; Tannenbaum C; Hamilton TA; Fairchild RL
J Immunol; 2000 Jun; 164(11):6027-33. PubMed ID: 10820287
[TBL] [Abstract][Full Text] [Related]
4. Monokine induced by interferon-gamma (MIG/CXCL9) is derived from both donor and recipient sources during rejection of class II major histocompatibility complex disparate skin allografts.
Auerbach MB; Shimoda N; Amano H; Rosenblum JM; Kish DD; Farber JM; Fairchild RL
Am J Pathol; 2009 Jun; 174(6):2172-81. PubMed ID: 19389928
[TBL] [Abstract][Full Text] [Related]
5. T cell infiltration into class II MHC-disparate allografts and acute rejection is dependent on the IFN-gamma-induced chemokine Mig.
Koga S; Auerbach MB; Engeman TM; Novick AC; Toma H; Fairchild RL
J Immunol; 1999 Nov; 163(9):4878-85. PubMed ID: 10528189
[TBL] [Abstract][Full Text] [Related]
6. Early up-regulation of CXC-chemokine expression is associated with strong cellular immune responses to murine skin xenografts.
Lee EM; Park JO; Kim D; Kim JY; Oh KH; Park CG; Oh BH; Kim S; Ahn C
Xenotransplantation; 2006 Jul; 13(4):328-36. PubMed ID: 16768726
[TBL] [Abstract][Full Text] [Related]
7. A synthetic CD4-CDR3 peptide analog enhances skin allograft survival across a MHC class II barrier.
Koch U; Choksi S; Marcucci L; Korngold R
J Immunol; 1998 Jul; 161(1):421-9. PubMed ID: 9647252
[TBL] [Abstract][Full Text] [Related]
8. The role of CD30 in skin and heart allograft rejection in the mouse.
Beckmann J; Kurts C; Klebba I; Bayer B; Klempnauer J; Hoffmann MW
Transplant Proc; 2001; 33(1-2):140-1. PubMed ID: 11266747
[No Abstract] [Full Text] [Related]
9. The use of MHC class I or class II "knock out" mice to investigate the role of these antigens in allosensitization.
Qian S; Fu F; Li Y; Gao L; Lu L; Noyola H; Rao AS; Thomson AW; Demetris AJ; Starzl TE
Transplant Proc; 1995 Feb; 27(1):475-6. PubMed ID: 7879067
[No Abstract] [Full Text] [Related]
10. The role of MIG/CXCL9 in cardiac allograft vasculopathy.
Yun JJ; Fischbein MP; Whiting D; Irie Y; Fishbein MC; Burdick MD; Belperio J; Strieter RM; Laks H; Berliner JA; Ardehali A
Am J Pathol; 2002 Oct; 161(4):1307-13. PubMed ID: 12368204
[TBL] [Abstract][Full Text] [Related]
11. Liver graft induced donor specific unresponsiveness without class I and/or class II antigen differences.
Qian S; Sun H; Demetris AJ; Fu F; Starzl TE; Fung JJ
Transplant Proc; 1993 Feb; 25(1 Pt 1):362-3. PubMed ID: 8438336
[No Abstract] [Full Text] [Related]
12. The role of HLA class II antigens/genes in xenogeneic iso, allo, and xeno transplantation.
Tsuji K; Hagihara M; Sato T; Shimura T; Takebe K; Munkhbat B
Transplant Proc; 1994 Aug; 26(4):2441-3. PubMed ID: 8066801
[No Abstract] [Full Text] [Related]
13. Comparison of tolerance inducibility to class I or class II antigens between cyclophosphamide (CP)-induced tolerance and transfusion with donor cells: general effectiveness of CP-induced tolerance and difference of skin graft prolongation in each class I antigen-disparate combination.
Tomita Y; Nomoto K
Immunobiology; 1992 Nov; 186(3-4):282-91. PubMed ID: 1490733
[TBL] [Abstract][Full Text] [Related]
14. Specific prolongation of MHC class II disparate skin allografts by in vivo administration of anti-IFN-gamma monoclonal antibody.
Rosenberg AS; Finbloom DS; Maniero TG; Van der Meide PH; Singer A
J Immunol; 1990 Jun; 144(12):4648-50. PubMed ID: 2112572
[TBL] [Abstract][Full Text] [Related]
15. Monokine induced by IFN-gamma is a dominant factor directing T cells into murine cardiac allografts during acute rejection.
Miura M; Morita K; Kobayashi H; Hamilton TA; Burdick MD; Strieter RM; Fairchild RL
J Immunol; 2001 Sep; 167(6):3494-504. PubMed ID: 11544343
[TBL] [Abstract][Full Text] [Related]
16. IL-4 deficiency prevents eosinophilic rejection and uncovers a role for neutrophils in the rejection of MHC class II disparate skin grafts.
Surquin M; Le Moine A; Flamand V; Rombaut K; Demoor FX; Salmon I; Goldman M; Abramowicz D
Transplantation; 2005 Nov; 80(10):1485-92. PubMed ID: 16340795
[TBL] [Abstract][Full Text] [Related]
17. Effects of intrathymic tolerance on mouse heart and skin allograft acceptance.
Tu Y; Arima T; Flye MW
Transplant Proc; 1997; 29(1-2):1063-4. PubMed ID: 9123200
[No Abstract] [Full Text] [Related]
18. Involvement of Th2-like T cells in regulating allograft reactivity against MHC class II-disparate antigen.
Maeda H; Ogoshi S; Fujimoto S
Transplant Proc; 1994 Apr; 26(2):847-8. PubMed ID: 8171685
[No Abstract] [Full Text] [Related]
19. Tolerance induction to skin allografts following intrathymic injection with donor-specific splenocytes in major histocompatibility complex class I, class I+MLS, and class I+II disparities.
Ohzato H; Monaco AP
Transplant Proc; 1993 Feb; 25(1 Pt 1):297-8. PubMed ID: 8438307
[No Abstract] [Full Text] [Related]
20. Chemokine monokine induced by IFN-gamma/CXC chemokine ligand 9 stimulates T lymphocyte proliferation and effector cytokine production.
Whiting D; Hsieh G; Yun JJ; Banerji A; Yao W; Fishbein MC; Belperio J; Strieter RM; Bonavida B; Ardehali A
J Immunol; 2004 Jun; 172(12):7417-24. PubMed ID: 15187119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
